Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Memormax
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Latis
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of MEMORMAX in Subjects With MCI
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 10, 2018
Lead Product(s) : Memormax
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Latis
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Neobianacid
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Doppel Pharma | University of Roma La Sapienza | BMR Genomics
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 03, 2017
Lead Product(s) : Neobianacid
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Doppel Pharma | University of Roma La Sapienza | BMR Genomics
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Promelaxin
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Euromed Pharma Services | Ceinge | Latis | PhAST Consulting
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 26, 2016
Lead Product(s) : Promelaxin
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Euromed Pharma Services | Ceinge | Latis | PhAST Consulting
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Artichoke Extract
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Recipient : Ontario Clinical Oncology Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 03, 2014
Lead Product(s) : Artichoke Extract
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Recipient : Ontario Clinical Oncology Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase IV
Recipient : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 24, 2013
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase IV
Recipient : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
